Newsroom | 193816 results

DALLAS--(BUSINESS WIRE)--Aethon Energy Management LLC (“Aethon”) today announced the formation of a Global Strategic Alliance with Mitsubishi Corporation (“Mitsubishi”), establishing a framework for collaboration on future commercial opportunities across energy transition and next-generation infrastructure projects on a global basis. The Global Strategic Alliance is intended to provide a platform for the parties to explore and evaluate potential projects in areas including liquefied natural gas...

SINGAPORE--(BUSINESS WIRE)--AM Best has maintained its outlook on India’s non-life insurance segment at stable, citing supportive macroeconomics, as well as insurance demand buttressed by regulatory initiatives and reforms. India’s non-life segment recorded mid-single-digit premium growth for the fiscal year ending 31 March 2025 (FY2025), according to the Best’s Market Segment Report, “Market Segment Outlook: India Non-Life Insurance.” Growth moderated relative to the prior year given the prici...

DALLAS--(BUSINESS WIRE)--MegPrime Holding, LLC and Megatel Homes, LLC one of the largest privately held real estate developers and homebuilders in the United States, have received a No-Action Letter from the SEC Staff paving the way for them to launch the first universal payments token. MegPrime is a fintech platform powered by its digital currency, the MP Token, built to turn everyday spending into real-world value and long-term financial progress. Designed as an open ecosystem for renters and...

GREENWICH, Conn.--(BUSINESS WIRE)--Interactive Brokers (Nasdaq: IBKR) announced that eligible clients of Interactive Brokers LLC can now fund their brokerage accounts using stablecoin....

ZURIGO, PHILADELPHIA e COPENHAGEN, Danimarca--(BUSINESS WIRE)--InterAx Biotech Ltd (“InterAx”) e Alveus Therapeutics Inc. (“Alveus”) oggi hanno annunciato un accordo strategico di licenza e collaborazione alla ricerca volto a sviluppare un candidato differenziato a piccola molecola per la malattia metabolica per offrire una terapia dimagrante durevole con tollerabilità superiore. Questa collaborazione fa parte di uno impegno di ricerca congiunta su un target e una modalità di interesse terapeut...

ZÜRICH & PHILADELPHIA & KOPENHAGEN, Denemarken--(BUSINESS WIRE)--InterAx Biotech Ltd ('InterAx') en Alveus Therapeutics Inc. ('Alveus') hebben vandaag een strategische samenwerkings- en licentieovereenkomst aangekondigd voor de ontwikkeling van een onderscheidend kandidaatmedicijn met kleine moleculen voor stofwisselingsziekten, gericht op duurzaam gewichtsverlies met een superieure verdraagbaarheid. Dit partnerschap vormt een gezamenlijke onderzoeksinspanning gericht op een doelwit en modalite...

ZÜRICH, PHILADELPHIA UND KOPENHAGEN, Dänemark--(BUSINESS WIRE)--InterAx Biotech Ltd („InterAx“) und Alveus Therapeutics Inc. („Alveus“) haben heute eine strategische Forschungskooperation und Lizenzvereinbarung zur Entwicklung eines differenzierten niedermolekularen Arzneimittelkandidaten für Stoffwechselerkrankungen bekannt gegeben, der eine dauerhafte Gewichtsreduktion bei hervorragender Verträglichkeit verspricht. Im Rahmen dieser Partnerschaft wird eine gemeinsame Forschungsinitiative zu ei...

ZURICH, PHILADELPHIE et COPENHAGUE, Danemark--(BUSINESS WIRE)--InterAx Biotech Ltd (« InterAx ») et Alveus Therapeutics Inc. (« Alveus ») ont annoncé aujourd'hui un accord de collaboration stratégique en matière de recherche et contrat de licence visant à développer une petite molécule candidate différenciée pour les maladies métaboliques afin d'obtenir une perte de poids durable ayant une meilleure une tolérance. Ce partenariat s'inscrit dans une recherche conjointe sur une cible et une modali...

ELIZABETHTOWN, Ky.--(BUSINESS WIRE)--LiaFi, a Fintech platform and app for small businesses, today announced it has increased the annual percentage yield on its LiaFi Business Account to 3.10% APY* for new and existing accounts. The rate increase reflects LiaFi’s continued efforts to help small businesses, organizations and non-profits better manage their cash reserves by providing a simple way to earn competitive interest on idle cash without sacrificing liquidity. “We’re passionate about smal...

GREENWICH, Conn.--(BUSINESS WIRE)--QXO, Inc. (“QXO” or the “Company”) (NYSE: QXO) today announced the following summarized preliminary financial information. The Company expects to file its annual report on Form 10-K for the year ended December 31, 2025 on February 26, 2026. FOURTH QUARTER 2025 SUMMARY PRELIMINARY RESULTS Net sales of approximately $2.19 billion Adjusted EBITDA of approximately $150 million The Company’s preliminary unaudited financial results in this press release for the four...